Meet IAG’s female technology leaders in a live discussion: sharing our story, career journey and aspirations.
The 8th March is International Women’s Day. This is the day for recognition and empowerment of our female leaders.
In 2021, this day marks nearly 12 months of the world’s covid troubles and importance of science.
2021 just calls to make this day extra special and talk about women in technology, science, and clinical research!
On this special day, we send our warmest wishes and want to invite you to join a live discussion with 4 inspirational female leaders of IAG. They will share their journey, career path and aspirations.
Dr. Olga Kubassova, IAG’s CEO and Founding Scientist, Dr. Diana Dupont-Roettger, IAG’s Chief Scientific Alliance Officer, Julia O’Lynn, IAG’s Imaging Specialist and Technologist, and Romiesa Hagoug, IAG’s Sn Project Manager.
Date and Time:
Friday, Mar 12th 2021
Time: 1 PM ET / 6 PM GMT
If you are interested in receiving a replay link, please email firstname.lastname@example.org
Key Discussion Points:
- My personal journey and joining clinical research industry,
- What does technology, science and entrepreneurship mean to me,
- My challenges and wins in day-to-day professional life,
- My aspirations, ambitions, and advice I want to give to the future leaders.
Followed by a discussion and Q&A.
Who Should Attend:
A person of any age, any gender, any occupation who feels that they can draw insights from our life stories and our journey and make these useful to your family, colleagues or friends.
If you cannot attend, just register and you will receive a replay link!
IAG is a strategic partner to bio-pharmaceutical companies developing new treatments to improve patients’ lives. Our dynamic Strategy, Trial Solutions and Bio-Partnering divisions work closely to meet critical needs of biotechnology companies: funding, clinical development and monetization of their assets. We fuse decades of therapeutic insights, risk-sharing business model and agile culture to accelerate novel drug development. IAG broadly leverages its core imaging expertise, proprietary technology platform DYNAMIKA and capabilities to support an objective early go no/ go decision and drive excellence for tomorrow’s innovative therapeutic agents with speed. www.ia-grp.com